Metraipolis › archive › dc_0c8088f7fe8a
Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency — Europe PMC PMID:42099591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42099591
- DOI
- 10.3389/fimmu.2026.1811502
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T00:04:22.891Z
- SHA-256 of the archived text
48084ad5453d62824eeea7740ef4855be9b39f98c40eea621739fc47eaef0d02- Stable URL of this page
https://metraipolis.com/documento/dc_0c8088f7fe8a
How to cite
Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency — Europe PMC PMID:42099591 — Europe PMC (en), https://europepmc.org/article/MED/42099591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c8088f7fe8a (Metraipolis archive dc_0c8088f7fe8a, sha256 48084ad5453d62824eeea7740ef4855be9b39f98c40eea621739fc47eaef0d02)
BibTeX
@misc{dc0c8088f7fe8a,
title = {Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency — Europe PMC PMID:42099591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42099591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c8088f7fe8a; sha256 48084ad5453d62824eeea7740ef4855be9b39f98c40eea621739fc47eaef0d02},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42099591. Agents can read the archived copy with the MCP tool read_document.